We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$102B
AUM Growth
+$6.21B
Cap. Flow
-$328M
Cap. Flow %
-0.32%
Top 10 Hldgs %
16.35%
Holding
9,167
New
1,076
Increased
3,582
Reduced
3,580
Closed
702

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.04B
2
C icon
Citigroup
C
+$374M
3
AMZN icon
Amazon
AMZN
+$352M
4
XL
XL Group Ltd.
XL
+$284M
5
PPG icon
PPG Industries
PPG
+$250M

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$288M
2
UNP icon
Union Pacific
UNP
+$283M
3
JPM icon
JPMorgan Chase
JPM
+$238M
4
AGN
Allergan plc
AGN
+$226M
5
ADM icon
Archer Daniels Midland
ADM
+$216M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.85%
2 Financials 7.52%
3 Industrials 6.64%
4 Energy 5.78%
5 Technology 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEO icon
3726
NeoGenomics
NEO
$2.05B
$939K ﹤0.01%
225,125
+72,283
+47% +$332K
PGEN icon
3727
PUT
Precigen
PGEN
$2.18B
$939K ﹤0.01%
35,680
+10,777
+43% +$236K
AEGR
3728
CALL
DELISTED
Aegerion Pharmaceuticals
AEGR
$936K ﹤0.01%
44,700
-42,800
-49% -$1.08M
NPK icon
3729
National Presto Industries
NPK
$1B
$934K ﹤0.01%
16,082
-557
-3% -$33.1K
FSL
3730
PUT
DELISTED
FREESCALE SEMICONDUCTOR LTD
FSL
$934K ﹤0.01%
37,000
+30,200
+444% +$628K
BAS
3731
DELISTED
Basis Energy Services, Inc.
BAS
$934K ﹤0.01%
234
-1,870
-89% -$11.8M
BPT
3732
PUT
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$933K ﹤0.01%
13,800
-7,600
-36% -$605K
UYG icon
3733
ProShares Ultra Financials
UYG
$860M
$933K ﹤0.01%
+37,530
New +$867K
LOCK
3734
PUT
DELISTED
LifeLock, Inc.
LOCK
$933K ﹤0.01%
50,400
+36,900
+273% +$608K
AEC
3735
DELISTED
ASSOCIATED ESTATES REALTY CORP
AEC
$933K ﹤0.01%
40,208
-8,498
-17% -$176K
CVRR
3736
PUT
DELISTED
CVR Refining, LP
CVRR
$932K ﹤0.01%
55,500
+40,300
+265% +$882K
PSXP
3737
PUT
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$931K ﹤0.01%
+13,500
New +$877K
EIX icon
3738
CALL
Edison International
EIX
$27.5B
$930K ﹤0.01%
14,200
+9,000
+173% +$559K
SRDX
3739
DELISTED
Surmodics
SRDX
$930K ﹤0.01%
42,064
+5,550
+15% +$118K
EDIV icon
3740
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
$929K ﹤0.01%
+27,234
New +$968K
PDLI
3741
DELISTED
PDL BioPharma, Inc.
PDLI
$928K ﹤0.01%
120,451
+51,804
+75% +$410K
KERX
3742
CALL
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$927K ﹤0.01%
65,500
+10,100
+18% +$157K
SALE
3743
CALL
DELISTED
RetailMeNot, Inc. Series 1
SALE
$927K ﹤0.01%
63,400
+33,900
+115% +$530K
CVE icon
3744
Cenovus Energy
CVE
$57.2B
$926K ﹤0.01%
44,930
+31,670
+239% +$729K
ALNY icon
3745
Alnylam Pharmaceuticals
ALNY
$30.6B
$925K ﹤0.01%
9,540
-241,810
-96% -$22.4M
MEMP
3746
DELISTED
Memorial Production Partners LP Common Units
MEMP
$924K ﹤0.01%
+63,341
New +$1.09M
RPV icon
3747
Invesco S&P 500 Pure Value ETF
RPV
$1.75B
$923K ﹤0.01%
+16,801
New +$901K
LUMO
3748
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$923K ﹤0.01%
2,581
+2,063
+398% +$614K
ACHC icon
3749
Acadia Healthcare
ACHC
$2.87B
$921K ﹤0.01%
15,047
+8,378
+126% +$488K
DFE icon
3750
WisdomTree Europe SmallCap Dividend Fund
DFE
$170M
$921K ﹤0.01%
17,895
+5,110
+40% +$262K
148 149
150
151 152

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q4 2014 Portfolio in Review

As of Q4 2014, Ken Griffin held 9,167 positions worth $102B, up 6.5% from $95.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ken Griffin's Q4 2014 filing shows 1,076 new, 3,582 increased, 3,580 reduced and 702 closed positions. Its largest new stake was SIGMA - ALDRICH CORP: 1,469,606 shares worth $202M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $288M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.8% of assets, up from 7.6% a quarter earlier, followed by Financials and Industrials.

  • Ken Griffin's largest Q4 2014 buy was SIGMA - ALDRICH CORP: 1,469,606 shares worth $202M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.04B increase.
  • Ken Griffin's biggest Q4 2014 reduction was Union Pacific, cutting an estimated $283M.
  • Ken Griffin fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, selling an estimated $288M.
  • Ken Griffin's ten largest holdings make up 16% of its $102B portfolio in Q4 2014.
  • Ken Griffin opened 1,076 new positions and closed 702 in Q4 2014.
  • Ken Griffin's portfolio value rose 6.5% quarter-over-quarter to $102B.

Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.